BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 18977322)

  • 1. Inflammation joins the "niche".
    Peinado H; Rafii S; Lyden D
    Cancer Cell; 2008 Nov; 14(5):347-9. PubMed ID: 18977322
    [TBL] [Abstract][Full Text] [Related]  

  • 2. S1PR1-STAT3 signaling is crucial for myeloid cell colonization at future metastatic sites.
    Deng J; Liu Y; Lee H; Herrmann A; Zhang W; Zhang C; Shen S; Priceman SJ; Kujawski M; Pal SK; Raubitschek A; Hoon DSB; Forman S; Figlin RA; Liu J; Jove R; Yu H
    Cancer Cell; 2012 May; 21(5):642-654. PubMed ID: 22624714
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proinflammatory S100 proteins regulate the accumulation of myeloid-derived suppressor cells.
    Sinha P; Okoro C; Foell D; Freeze HH; Ostrand-Rosenberg S; Srikrishna G
    J Immunol; 2008 Oct; 181(7):4666-75. PubMed ID: 18802069
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myeloid cells in cancer-related inflammation.
    Caronni N; Savino B; Bonecchi R
    Immunobiology; 2015 Feb; 220(2):249-53. PubMed ID: 25454487
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myeloid-specific expression of Api6/AIM/Sp alpha induces systemic inflammation and adenocarcinoma in the lung.
    Qu P; Du H; Li Y; Yan C
    J Immunol; 2009 Feb; 182(3):1648-59. PubMed ID: 19155514
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of PPARγ in myeloid-lineage cells induces systemic inflammation, immunosuppression, and tumorigenesis.
    Wu L; Yan C; Czader M; Foreman O; Blum JS; Kapur R; Du H
    Blood; 2012 Jan; 119(1):115-26. PubMed ID: 22053106
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Osteopontin shapes immunosuppression in the metastatic niche.
    Sangaletti S; Tripodo C; Sandri S; Torselli I; Vitali C; Ratti C; Botti L; Burocchi A; Porcasi R; Tomirotti A; Colombo MP; Chiodoni C
    Cancer Res; 2014 Sep; 74(17):4706-19. PubMed ID: 25035397
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Energy Sparing Orexigenic Inflammation of Obesity.
    Lee A; Dixit VD
    Cell Metab; 2017 Jul; 26(1):10-12. PubMed ID: 28683278
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overcoming Therapeutic Resistance by Targeting Cancer Inflammation.
    Beatty GL
    Am Soc Clin Oncol Educ Book; 2016; 35():e168-73. PubMed ID: 27249720
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic psychological stress promotes lung metastatic colonization of circulating breast cancer cells by decorating a pre-metastatic niche through activating β-adrenergic signaling.
    Chen H; Liu D; Guo L; Cheng X; Guo N; Shi M
    J Pathol; 2018 Jan; 244(1):49-60. PubMed ID: 28940209
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CDA-2, a urinary preparation, inhibits lung cancer development through the suppression of NF-kappaB activation in myeloid cell.
    Wang X; Jiang CM; Wan HY; Wu JL; Quan WQ; Bals R; Wu KY; Li D
    PLoS One; 2012; 7(12):e52117. PubMed ID: 23284890
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of PPARγ in myeloid cells promotes lung cancer progression and metastasis.
    Li H; Sorenson AL; Poczobutt J; Amin J; Joyal T; Sullivan T; Crossno JT; Weiser-Evans MC; Nemenoff RA
    PLoS One; 2011; 6(12):e28133. PubMed ID: 22145026
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retinoid X receptor suppresses a metastasis-promoting transcriptional program in myeloid cells via a ligand-insensitive mechanism.
    Kiss M; Czimmerer Z; Nagy G; Bieniasz-Krzywiec P; Ehling M; Pap A; Poliska S; Boto P; Tzerpos P; Horvath A; Kolostyak Z; Daniel B; Szatmari I; Mazzone M; Nagy L
    Proc Natl Acad Sci U S A; 2017 Oct; 114(40):10725-10730. PubMed ID: 28923935
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SHIP represses lung inflammation and inhibits mammary tumor metastasis in BALB/c mice.
    Hamilton MJ; Halvorsen EC; LePard NE; Bosiljcic M; Ho VW; Lam V; Banáth J; Bennewith KL; Krystal G
    Oncotarget; 2016 Jan; 7(4):3677-91. PubMed ID: 26683227
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CCL9 Induced by TGFβ Signaling in Myeloid Cells Enhances Tumor Cell Survival in the Premetastatic Organ.
    Yan HH; Jiang J; Pang Y; Achyut BR; Lizardo M; Liang X; Hunter K; Khanna C; Hollander C; Yang L
    Cancer Res; 2015 Dec; 75(24):5283-98. PubMed ID: 26483204
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A mutual activation loop between breast cancer cells and myeloid-derived suppressor cells facilitates spontaneous metastasis through IL-6 trans-signaling in a murine model.
    Oh K; Lee OY; Shon SY; Nam O; Ryu PM; Seo MW; Lee DS
    Breast Cancer Res; 2013; 15(5):R79. PubMed ID: 24021059
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myeloid WNT7b mediates the angiogenic switch and metastasis in breast cancer.
    Yeo EJ; Cassetta L; Qian BZ; Lewkowich I; Li JF; Stefater JA; Smith AN; Wiechmann LS; Wang Y; Pollard JW; Lang RA
    Cancer Res; 2014 Jun; 74(11):2962-73. PubMed ID: 24638982
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of the B-cell receptor component CD79a on immature myeloid cells contributes to their tumor promoting effects.
    Luger D; Yang YA; Raviv A; Weinberg D; Banerjee S; Lee MJ; Trepel J; Yang L; Wakefield LM
    PLoS One; 2013; 8(10):e76115. PubMed ID: 24146823
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myeloid cell heterogeneity in lung cancer: implication for immunotherapy.
    Sangaletti S; Ferrara R; Tripodo C; Garassino MC; Colombo MP
    Cancer Immunol Immunother; 2021 Sep; 70(9):2429-2438. PubMed ID: 33797567
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myeloid regulatory cells in tumor spreading and metastasis.
    Keskinov AA; Shurin MR
    Immunobiology; 2015 Feb; 220(2):236-42. PubMed ID: 25178934
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.